C

CSPC Pharmaceutical Group Ltd
HKEX:1093

Watchlist Manager
CSPC Pharmaceutical Group Ltd
HKEX:1093
Watchlist
Price: 4.8 HKD -0.21% Market Closed
Market Cap: 56.1B HKD
Have any thoughts about
CSPC Pharmaceutical Group Ltd?
Write Note

Operating Margin
CSPC Pharmaceutical Group Ltd

22.3%
Current
24%
Average
6.8%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
22.3%
=
Operating Profit
6.8B
/
Revenue
30.3B

Operating Margin Across Competitors

Country CN
Market Cap 57.1B HKD
Operating Margin
22%
Country JP
Market Cap 776 550.9T JPY
Operating Margin
-83%
Country US
Market Cap 741.7B USD
Operating Margin
35%
Country UK
Market Cap 440.4B GBP
Operating Margin
3%
Country DK
Market Cap 2.8T DKK
Operating Margin
44%
Country US
Market Cap 346.4B USD
Operating Margin
28%
Country US
Market Cap 250B USD
Operating Margin
34%
Country CH
Market Cap 199.8B CHF
Operating Margin
32%
Country UK
Market Cap 161.8B GBP
Operating Margin
21%
Country CH
Market Cap 171.7B CHF
Operating Margin
31%
Country US
Market Cap 148.7B USD
Operating Margin
22%
No Stocks Found

CSPC Pharmaceutical Group Ltd
Glance View

Market Cap
57.1B HKD
Industry
Pharmaceuticals

CSPC Pharmaceutical Group Ltd., a prominent player in the pharmaceutical industry, has charted a strategic path focused on innovation and a diversified portfolio. The company, with its roots in China, has emerged as a formidable force by blending traditional pharmaceutical manufacturing with a strong emphasis on research and development. CSPC's journey is characterized by a commitment to developing high-quality generic drugs, innovative therapeutics, and nutritional products. The company's core business revolves around the production and sale of a wide range of pharmaceuticals, including cardiovascular drugs, oncology treatments, and central nervous system therapies. By leveraging advanced technology and robust research initiatives, CSPC consistently delivers solutions that address both common and complex healthcare needs across the globe. With a strategic focus on both domestic and international markets, CSPC Pharmaceutical Group capitalizes on its extensive distribution network to maximize reach and impact. The company has made significant investments in its production capabilities to maintain stringent quality standards while achieving cost efficiency. Furthermore, CSPC's earnings are bolstered by its expanding pipeline of innovative drugs, developed in-house and through strategic collaborations, which aims to capture emerging therapeutic areas. Overall, CSPC's blend of traditional pharmaceutical expertise, a focus on innovation, and strategic market positioning enables it to maintain a strong operational foothold and to consistently drive revenue growth in an ever-evolving industry landscape.

Intrinsic Value
7.28 HKD
Undervaluation 34%
Intrinsic Value
Price
C

See Also

Discover More
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
22.3%
=
Operating Profit
6.8B
/
Revenue
30.3B
What is the Operating Margin of CSPC Pharmaceutical Group Ltd?

Based on CSPC Pharmaceutical Group Ltd's most recent financial statements, the company has Operating Margin of 22.3%.